Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200059556Phase 4Not yet recruiting
Phase 4, randomised trial of oxytocin in uterine atony and intraoperative hypotension (IOH) (4 arms), sponsored by Linping District Women and Children Care Hospital. Primary endpoint: Success rate of treating uterine atony. Planned start May 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200059556.